GENEFILL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Genefill Soft Touch
Genefill Soft Touch - also known as Genefill Soft Touch filler - is a biphasic cross-linked hyaluronic acid dermal filler by GENEFILL, designed for superficial folds and fine lines, especially the periorbital area, perioral area and crow's feet. It is commonly chosen by aesthetic practitioners and clinics to treat crow's feet and periorbital and perioral lines. The product combines cross-linked hyaluronic acid (16 mg/mL) with non-cross-linked hyaluronic acid (2 mg/mL) in a 1 mL syringe, and is intended for professional intradermal injection only.
Key Benefits of Genefill Soft Touch
- Improves skin texture
- Enhances skin hydration
- Helps smooth superficial folds
- Supports treatment of periorbital and perioral lines
- Provides delicate, natural-looking results
- CE-marked (Notified Body 2409)
Indications and Professional Use
Main indications
- Periorbital area
- Perioral area
- Superficial folds
- Crow's feet
- Periorbital lines
- Perioral lines
- Skin texture improvement
- Hydration enhancement
Professional use
Professional use: For use only by trained medical personnel, administered by intradermal injection into the mid-dermis. Contraindications: Do not use for breast augmentation. Do not use for genital augmentation. Do not inject into blood vessels. Patients prone to hypertrophic or keloid scarring. Intolerance to gram-positive bacteria. Active inflammatory or infectious processes. Acute or chronic skin diseases. Anticoagulant therapy. Known allergy to hyaluronic acid. Autoimmune diseases. Pregnancy or lactation. Patients under 18 years old. Patients with multiple allergies should be excluded from treatment.
Treatment areas
- Periorbital area
- Perioral area
- Crow's feet
Patient profile
Patient suitability is determined by the treating practitioner following clinical assessment. Not suitable for patients under 18, pregnant or breastfeeding, with autoimmune disease, acute or chronic skin disease, a tendency to hypertrophic or keloid scarring, multiple allergies, known hypersensitivity to hyaluronic acid, intolerance to gram-positive bacteria, active inflammatory or infectious processes, or those undergoing anticoagulant therapy.
How Genefill Soft Touch Works
Genefill Soft Touch works through a biphasic combination of cross-linked hyaluronic acid (16 mg/mL) and non-cross-linked hyaluronic acid (2 mg/mL), injected into the mid-dermis. This improves skin texture and hydration while smoothing superficial folds, crow's feet, and periorbital and perioral lines, with a delicate, natural-looking effect suited to fine facial areas around the eyes and mouth.
Why Order From Allpara
Allpara offers genuine, verified GENEFILL products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Does Genefill Soft Touch contain lidocaine?
No. Genefill Soft Touch does not contain lidocaine. Its composition is hyaluronic acid, sodium chloride and water for injection. A local anaesthetic may be administered separately at the practitioner's discretion.
How is Genefill Soft Touch supplied?
Genefill Soft Touch is supplied as a 1 mL syringe with two sterile 30G needles included.
Where is Genefill Soft Touch injected?
Genefill Soft Touch is injected intradermally into the superficial to mid-dermis.
How long do Genefill Soft Touch results last?
The manufacturer does not publish a fixed duration; longevity varies with injection depth and treatment area.
Who should not use Genefill Soft Touch?
Genefill Soft Touch should not be used for breast or genital augmentation, in patients under 18, during pregnancy or breastfeeding, or in patients with autoimmune disease, acute or chronic skin disease, a tendency to hypertrophic or keloid scarring, multiple allergies, known hypersensitivity to hyaluronic acid, or those undergoing anticoagulant therapy.
More from BioScience
HYACORP references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
HYACORP Products
View all 6Clinic alternatives
Pick up where you left off
Genefill Soft Touch
Genefill Soft Touch - also known as Genefill Soft Touch filler - is a biphasic cross-linked hyaluronic acid dermal filler by GENEFILL, designed for superficial folds and fine lines, especially the periorbital area, perioral area and crow's feet. It is commonly chosen by aesthetic practitioners and clinics to treat crow's feet and periorbital and perioral lines. The product combines cross-linked hyaluronic acid (16 mg/mL) with non-cross-linked hyaluronic acid (2 mg/mL) in a 1 mL syringe, and is intended for professional intradermal injection only.
Key Benefits of Genefill Soft Touch
- Improves skin texture
- Enhances skin hydration
- Helps smooth superficial folds
- Supports treatment of periorbital and perioral lines
- Provides delicate, natural-looking results
- CE-marked (Notified Body 2409)
Indications and Professional Use
Main indications
- Periorbital area
- Perioral area
- Superficial folds
- Crow's feet
- Periorbital lines
- Perioral lines
- Skin texture improvement
- Hydration enhancement
Professional use
Professional use: For use only by trained medical personnel, administered by intradermal injection into the mid-dermis. Contraindications: Do not use for breast augmentation. Do not use for genital augmentation. Do not inject into blood vessels. Patients prone to hypertrophic or keloid scarring. Intolerance to gram-positive bacteria. Active inflammatory or infectious processes. Acute or chronic skin diseases. Anticoagulant therapy. Known allergy to hyaluronic acid. Autoimmune diseases. Pregnancy or lactation. Patients under 18 years old. Patients with multiple allergies should be excluded from treatment.
Treatment areas
- Periorbital area
- Perioral area
- Crow's feet
Patient profile
Patient suitability is determined by the treating practitioner following clinical assessment. Not suitable for patients under 18, pregnant or breastfeeding, with autoimmune disease, acute or chronic skin disease, a tendency to hypertrophic or keloid scarring, multiple allergies, known hypersensitivity to hyaluronic acid, intolerance to gram-positive bacteria, active inflammatory or infectious processes, or those undergoing anticoagulant therapy.
How Genefill Soft Touch Works
Genefill Soft Touch works through a biphasic combination of cross-linked hyaluronic acid (16 mg/mL) and non-cross-linked hyaluronic acid (2 mg/mL), injected into the mid-dermis. This improves skin texture and hydration while smoothing superficial folds, crow's feet, and periorbital and perioral lines, with a delicate, natural-looking effect suited to fine facial areas around the eyes and mouth.
Why Order From Allpara
Allpara offers genuine, verified GENEFILL products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Does Genefill Soft Touch contain lidocaine?
No. Genefill Soft Touch does not contain lidocaine. Its composition is hyaluronic acid, sodium chloride and water for injection. A local anaesthetic may be administered separately at the practitioner's discretion.
How is Genefill Soft Touch supplied?
Genefill Soft Touch is supplied as a 1 mL syringe with two sterile 30G needles included.
Where is Genefill Soft Touch injected?
Genefill Soft Touch is injected intradermally into the superficial to mid-dermis.
How long do Genefill Soft Touch results last?
The manufacturer does not publish a fixed duration; longevity varies with injection depth and treatment area.
Who should not use Genefill Soft Touch?
Genefill Soft Touch should not be used for breast or genital augmentation, in patients under 18, during pregnancy or breastfeeding, or in patients with autoimmune disease, acute or chronic skin disease, a tendency to hypertrophic or keloid scarring, multiple allergies, known hypersensitivity to hyaluronic acid, or those undergoing anticoagulant therapy.